(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.09%) $79.07
(0.16%) $1.935
(0.91%) $2 332.10
(0.79%) $26.96
(1.08%) $965.20
(0.00%) $0.933
(-0.01%) $11.03
(-0.07%) $0.798
(0.06%) $93.51
6.60% £ 30.70
Live Chart Being Loaded With Signals
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally...
Stats | |
---|---|
Объем за сегодня | 149 734 |
Средний объем | 319 187 |
Рыночная капитализация | 139.30M |
EPS | £0 ( 2024-03-25 ) |
Last Dividend | £1.200 ( 2022-11-02 ) |
Next Dividend | £0 ( N/A ) |
P/E | 30.70 |
ATR14 | £0.539 (1.76%) |
EKF Diagnostics Holdings Корреляция
10 Самые положительные корреляции | |
---|---|
MPL.L | 0.932 |
PDL.L | 0.924 |
TPX.L | 0.923 |
OMIP.L | 0.916 |
RDT.L | 0.913 |
SCLP.L | 0.913 |
3SNV.L | 0.909 |
TBLD.L | 0.909 |
3SUB.L | 0.906 |
DSW.L | 0.902 |
10 Самые отрицательные корреляции | |
---|---|
AEXG.L | -0.959 |
EMR.L | -0.958 |
CFX.L | -0.957 |
INSE.L | -0.949 |
SPEC.L | -0.939 |
VAST.L | -0.939 |
SKL.L | -0.938 |
NWT.L | -0.934 |
IPF.L | -0.932 |
GRA.L | -0.926 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
EKF Diagnostics Holdings Финансовые показатели
Annual | 2023 |
Выручка: | £52.61M |
Валовая прибыль: | £24.44M (46.45 %) |
EPS: | £0.00520 |
FY | 2023 |
Выручка: | £52.61M |
Валовая прибыль: | £24.44M (46.45 %) |
EPS: | £0.00520 |
FY | 2022 |
Выручка: | £66.64M |
Валовая прибыль: | £24.04M (36.07 %) |
EPS: | £-0.0209 |
FY | 2021 |
Выручка: | £81.84M |
Валовая прибыль: | £39.37M (48.10 %) |
EPS: | £0.0347 |
Financial Reports:
No articles found.
EKF Diagnostics Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£1.200 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.000 | 2020-11-04 |
Last Dividend | £1.200 | 2022-11-02 |
Next Dividend | £0 | N/A |
Payout Date | 2022-12-01 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | £3.30 | -- |
Avg. Dividend % Per Year | 0.73% | -- |
Score | 3.09 | -- |
Div. Sustainability Score | 9.77 | |
Div.Growth Potential Score | 5.28 | |
Div. Directional Score | 7.52 | -- |
Year | Amount | Yield |
---|---|---|
2020 | £1.000 | 2.98% |
2021 | £1.100 | 1.62% |
2022 | £1.200 | 1.58% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RECI.L | Dividend King | 2023-09-21 | Quarterly | 19 | 5.01% | |
GRID.L | Dividend Knight | 2023-09-14 | Quarterly | 6 | 3.17% | |
ARC.L | Ex Dividend Knight | 2023-10-05 | Annually | 8 | 1.10% | |
TTG.L | Dividend Junior | 2023-09-14 | Annually | 32 | 2.04% | |
MGCI.L | Dividend King | 2023-08-03 | Quarterly | 6 | 3.54% | |
CTG.L | Dividend Junior | 2023-10-05 | Annually | 28 | 1.34% | |
SCF.L | Dividend Knight | 2023-07-06 | Quarterly | 30 | 2.18% | |
HUR.L | Dividend King | 2023-06-08 | Insufficient data to determine frequency | 2 | 21.63% | |
BERI.L | Dividend Knight | 2023-09-28 | Quarterly | 19 | 2.36% | |
WINK.L | Dividend King | 2023-07-20 | Quarterly | 15 | 3.81% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0447 | 1.500 | 9.11 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0291 | 1.200 | 9.03 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0358 | 1.500 | -0.713 | -1.070 | [0.1 - 1] |
payoutRatioTTM | 2.32 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.69 | 0.800 | 1.545 | 1.236 | [1 - 3] |
quickRatioTTM | 1.768 | 0.800 | 4.31 | 3.45 | [0.8 - 2.5] |
cashRatioTTM | 0.814 | 1.500 | 6.59 | 9.89 | [0.2 - 2] |
debtRatioTTM | 0.0507 | -1.500 | 9.16 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 63.41 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0139 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00146 | 2.00 | -0.000732 | -0.00146 | [0 - 20] |
debtEquityRatioTTM | 0.0611 | -1.500 | 9.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.464 | 1.000 | 5.59 | 5.59 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0904 | 1.000 | -0.192 | -0.192 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.540 | 1.000 | 2.56 | 2.56 | [0.2 - 2] |
assetTurnoverTTM | 0.651 | 0.800 | 9.00 | 7.20 | [0.5 - 2] |
Total Score | 9.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 55.56 | 1.000 | 4.49 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0358 | 2.50 | -0.458 | -1.070 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00146 | 2.00 | -0.000488 | -0.00146 | [0 - 30] |
dividendYielPercentageTTM | 4.17 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0139 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.32 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 55.56 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.50 | 0 | [0.1 - 0.5] |
Total Score | 5.28 |
EKF Diagnostics Holdings
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа